US and EU regulators form 'cluster' to aid pharmacovigilance info exchange
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration and the European Medicines Agency have established a so-called "cluster" to exchange information via videoconference about pharmacovigilance topics1,2.